Primary Device ID | 04650075335949 |
NIH Device Record Key | 2b3caf7e-d752-4ddf-a4fa-fbf04ea7e135 |
Commercial Distribution Status | In Commercial Distribution |
Brand Name | CloudTMS Edge for OCD |
Version Model Number | Irbis cooling unit |
Company DUNS | 643212926 |
Company Name | NEUROSOFT, OOO |
Device Count | 1 |
DM Exempt | false |
Pre-market Exempt | false |
MRI Safety Status | Labeling does not contain MRI Safety Information |
Human Cell/Tissue Product | false |
Device Kit | false |
Device Combination Product | false |
Single Use | false |
Lot Batch | false |
Serial Number | true |
Manufacturing Date | true |
Expiration Date | false |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | false |
OTC Over-The-Counter | false |
Phone | 617 8403253 |
Jjabre@teleemg.com | |
Phone | 617 8403253 |
Jjabre@teleemg.com | |
Phone | 617 8403253 |
Jjabre@teleemg.com | |
Phone | 617 8403253 |
Jjabre@teleemg.com | |
Phone | 617 8403253 |
Jjabre@teleemg.com | |
Phone | 617 8403253 |
Jjabre@teleemg.com | |
Phone | 617 8403253 |
Jjabre@teleemg.com | |
Phone | 617 8403253 |
Jjabre@teleemg.com | |
Phone | 617 8403253 |
Jjabre@teleemg.com | |
Phone | 617 8403253 |
Jjabre@teleemg.com | |
Phone | 617 8403253 |
Jjabre@teleemg.com | |
Phone | 617 8403253 |
Jjabre@teleemg.com | |
Phone | 617 8403253 |
Jjabre@teleemg.com | |
Phone | 617 8403253 |
Jjabre@teleemg.com | |
Phone | 617 8403253 |
Jjabre@teleemg.com | |
Phone | 617 8403253 |
Jjabre@teleemg.com | |
Phone | 617 8403253 |
Jjabre@teleemg.com |
Device Issuing Agency | Device ID |
---|---|
GS1 | 04650075335949 [Primary] |
QCI | Transcranial Magnetic Stimulation System For Obsessive-Compulsive Disorder |
Steralize Prior To Use | false |
Device Is Sterile | false |
Public Version Status | New |
Device Record Status | Published |
Public Version Number | 1 |
Public Version Date | 2024-01-22 |
Device Publish Date | 2024-01-12 |
04650075335949 | No description |
04650075335895 | The CloudTMS Edge stimulator is intended to be used as an adjunct for the treatment of adult pat |